HBA Global Impact Award

1. Leadership Excellence (suggested word count limit: 400-500 words)

How has your company supported employee and executive leader growth to advance the future talent workforce—through development, mentorship, and retention? 

Here are suggested examples and/or metrics to include in response:  

• Percent of C-suite or Executive Leadership based outside of United States;
• Budget investment or supported hours for leadership initiatives;
• Percent of employees engaged in external development programs.  

2. Transformative Innovation (suggested word count limit: 400-500 words)

How does your company use next-generation solutions (AI, digital health platforms, apps or other emerging technologies) to improve both the future talent pipeline and patient outcomes? 

Here are suggested examples and/or metrics to include in response:  

• Number of company investments in new innovation initiatives with measurable impact on patient outcomes or workforce efficiencies;
• Efficiency gains (e.g., reduced time-to-market, improved workflows);
• Data/Evidence supporting that clinical trial design represents patient population;
• Demonstrated improvements in patient outcomes resulting from innovation. 

3. Business Impact (suggested word count limit: 400-500 words)

How have your company’s initiatives directly contributed to measurable business performance and improved patient or population health outcomes? 

Here are suggested examples and/or metrics to include in response: 

• Financial outcomes (e.g., revenue growth, cost savings);
• Operational efficiency (e.g., productivity, innovation adoption).;
• Health outcomes (e.g., patient satisfaction, quality of care) across populations served 

4. Industry Collaboration (suggested word count limit: 400-500 words)

How has your company advanced shared healthcare goals through global collaboration with either industry partners and/or organizations such as the HBA? 

Here are suggested examples and/or metrics to include in response: 

• List program collaborations/partnerships with global impact and outcomes;
• Percentage increase in patient populations gaining access to healthcare through partnerships;
• Evidence of sustainable healthcare system improvements (for patients or workplace talent) through collaborations. 

The HBA Global Impact Award is more than a recognition—it's a celebration of bold vision, inclusive leadership, and meaningful change. If your organization is driving innovation, empowering talent, and making a measurable difference in healthcare, we encourage you to share your story. 

Do companies need to be HBA Corporate Partners to apply? 

No. Any organization may apply—a corporate partnership with the HBA is not a requirement. 

As part of the evaluation, judges will consider how your company collaborates with industry partners and other organizations (like the HBA) that offer talent and leadership development programs and networking opportunities for employees.  

What are the award criteria? 

Submissions will be evaluated across four key dimensions: 

• Leadership Excellence – How your company cultivates and retains future-ready talent through leadership development, mentorship, and global representation. 

• Transformative Innovation – Use of emerging technologies (e.g., AI, digital health) to improve patient outcomes and workforce capabilities. 

• Business Impact – Demonstrated results in financial performance, operational efficiency, and improved health outcomes. 

• Industry Collaboration – Evidence of meaningful partnerships that expand access, improve systems, or drive sustainable change across the healthcare ecosystem.

What should be included in the submission? 

To strengthen your nomination, it is recommended that you include quantitative and qualitative evidence in your responses. This may include: 

• Data and metrics that demonstrate measurable outcomes
• Case studies that illustrate real-world impact
• Examples that bring your initiatives to life 

 This level of detail helps judges fully understand the scale, depth, and significance of your organization’s contributions to global healthcare transformation. 

What are the expectations for finalists? 

Finalists will be notified in early December. While the announcement will remain under embargo until 12 January, we strongly encourage finalists to have representatives attend the HBA reception at JP Morgan that day. 

Finalists are also expected to attend the Global Ascension Awards in San Diego, 23–24 April, where the winner will be revealed and celebrated alongside the broader HBA community. 

How are nominations evaluated? 

• Submissions are reviewed by a confidential selection committee of senior industry leaders aligned with HBA’s mission. 

• Each judge independently scores submissions based on the defined criteria. 

• The committee then discusses and selects the honorees based on collective evaluation and merit. 

Can the same person or company be nominated for multiple awards? 

Yes. There is no limit to how many awards a person or company can be nominated for—or how many times they can be resubmitted in future years.

Is there a submission fee? 

Yes. The nomination fee is: 

• $1,000 for HBA members 

• $1,250 for non-members 

Do the nominators or submitters influence the outcome? 

No. The strength of the nomination including quantitative, qualitative data and examples that bring initiatives to life are what matter most. The identity of the person submitting the nomination does not influence the outcome.